FDA Inspection 1333064 — Cyrille Touzeau, MD, PhD

Cyrille Touzeau, MD, PhD — FEI 3044161195

The FDA completed an inspection of Cyrille Touzeau, MD, PhD on Aug 14, 2026 in Nantes. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.